Stress: A Possible Link between Genetics, Epigenetics, and Childhood Asthma
T-Cell Immunotherapy in Cystic Fibrosis
Considerations for Targeting β-Catenin Signaling in Fibrosis
Angiotensin-Converting Enzyme 2 Activation for Treatment of Pulmonary Hypertension
Implications of the U.S. Food and Drug Administration Warning against the Use of Sildenafil for the Treatment of Pediatric Pulmonary Hypertension
Exercise-induced Pulmonary Hypertension
ADCYAP1R1 and Asthma in Puerto Rican Children
Pathogenic Bacteria Colonizing the Airways in Asymptomatic Neonates Stimulates Topical Inflammatory Mediator Release
Quantifying Health Services Use for Chronic Obstructive Pulmonary Disease
Mortality by Level of Emphysema and Airway Wall Thickness
Th17/Treg Imbalance in Murine Cystic Fibrosis Is Linked to Indoleamine 2,3-Dioxygenase Deficiency but Corrected by Kynurenines
A Th17- and Th2-skewed Cytokine Profile in Cystic Fibrosis Lungs Represents a Potential Risk Factor for Pseudomonas aeruginosa Infection
β-Catenin in the Alveolar Epithelium Protects from Lung Fibrosis after Intratracheal Bleomycin
Reestablishment of Recipient-associated Microbiota in the Lung Allograft Is Linked to Reduced Risk of Bronchiolitis Obliterans Syndrome
Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models
Catamenial Hemoptysis
A Call to Apply the Minimal Important Difference in Pulmonary Arterial Hypertension beyond the Flawed 6-Minute-Walk Test
Reply: A Call to Apply the Minimal Important Difference in Pulmonary Arterial Hypertension beyond the Flawed 6-Minute-Walk Test
The Usefulness of Kco Is Questionable
Reply: The Usefulness of Kco Is Questionable
Amphotericin B Deoxycholate for Candidiasis in Intensive Care Unit Patients Revisited: Medical, Ethical, and Financial Implications
Exonic Mutations of TSC2/TSC1 Are Common but Not Seen in All Sporadic Pulmonary Lymphangioleiomyomatosis
The Petrified Lung